MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology
- PMID: 38194804
- DOI: 10.1016/j.prp.2024.155091
MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology
Abstract
MicroRNA-21 (miR-21) was recognized as a key figure in the intricate web of tumor biology, with a prominent role in regulating the PTEN tumor suppressor gene and the PI3K/AKT cascade. This review elucidates the multifaceted interactions between miR-21, PTEN, and the PI3K/AKT signaling, shedding light on their profound implications in cancer initiation, progression, and therapeutic strategies. The core of this review delves into the mechanical intricacies of miR-21-mediated PTEN suppression and its consequent impact on PI3K/AKT pathway activation. It explores how miR-21, as an oncogenic miRNA, targets PTEN directly or indirectly, resulting in uncontrolled activation of PI3K/AKT, fostering cancerous cell survival, proliferation, and evasion of apoptosis. Furthermore, the abstract emphasizes the clinical relevance of these molecular interactions, discussing their implications in various cancer types, prognostic significance, and potential as therapeutic targets. The review provides insights into ongoing research efforts to develop miR-21 inhibitors and strategies to restore PTEN function, offering new avenues for cancer treatment. This article illuminates the critical function of miR-21 in PTEN suppression and PI3K/AKT activation, offering profound insights into its implications for cancer biology and the potential for targeted interventions.
Keywords: Cancer; Epigenetics; MicroRNA-21; PI3K/AKT; PTEN.
Copyright © 2024 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no conflict of interest.
Similar articles
-
Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.J Cell Biochem. 2017 Oct;118(10):3424-3434. doi: 10.1002/jcb.25999. Epub 2017 May 30. J Cell Biochem. 2017. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S55. doi: 10.1002/jcb.30023. PMID: 28322459 Retracted.
-
MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.Cancer Sci. 2017 Apr;108(4):620-631. doi: 10.1111/cas.13177. Epub 2017 Apr 19. Cancer Sci. 2017. PMID: 28132399 Free PMC article.
-
MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.Mol Cells. 2018 Jun;41(6):532-544. doi: 10.14348/molcells.2018.2211. Epub 2018 Jun 14. Mol Cells. 2018. PMID: 29902839 Free PMC article.
-
PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.Mol Cancer. 2018 Feb 19;17(1):37. doi: 10.1186/s12943-018-0803-3. Mol Cancer. 2018. PMID: 29455665 Free PMC article. Review.
-
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions.Biomed Pharmacother. 2023 Feb;158:114204. doi: 10.1016/j.biopha.2022.114204. Epub 2023 Jan 4. Biomed Pharmacother. 2023. PMID: 36916430 Review.
Cited by
-
Ovarian aging: energy metabolism of oocytes.J Ovarian Res. 2024 May 31;17(1):118. doi: 10.1186/s13048-024-01427-y. J Ovarian Res. 2024. PMID: 38822408 Free PMC article. Review.
-
Correlation and predictive modeling of serum exosomal miRNAs and serological biomarkers for lymph node metastasis in gastric cancer.Am J Cancer Res. 2025 Jun 15;15(6):2579-2594. doi: 10.62347/AOJE4206. eCollection 2025. Am J Cancer Res. 2025. PMID: 40667557 Free PMC article.
-
LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response.Int J Mol Sci. 2024 Jul 29;25(15):8264. doi: 10.3390/ijms25158264. Int J Mol Sci. 2024. PMID: 39125832 Free PMC article.
-
How MicroRNAs Command the Battle against Cancer.Int J Mol Sci. 2024 May 28;25(11):5865. doi: 10.3390/ijms25115865. Int J Mol Sci. 2024. PMID: 38892054 Free PMC article. Review.
-
Assessing the safety of bedaquiline: insight from adverse event reporting system analysis.Front Pharmacol. 2024 May 9;15:1382441. doi: 10.3389/fphar.2024.1382441. eCollection 2024. Front Pharmacol. 2024. PMID: 38783951 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials